{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:46:02Z","timestamp":1773708362323,"version":"3.50.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T00:00:00Z","timestamp":1312502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00784-011-0596-x","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T14:07:00Z","timestamp":1312466820000},"page":"1143-1152","source":"Crossref","is-referenced-by-count":55,"title":["Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap"],"prefix":"10.1007","volume":"16","author":[{"given":"Juliana","family":"Lemound","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e8","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Kokem\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"von See","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pit Jacob","family":"Voss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Tavassol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"R\u00fccker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majeed","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils-Claudius","family":"Gellrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"key":"596_CR1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1258\/0004563011901037","volume":"38","author":"SD Vasikaran","year":"2001","unstructured":"Vasikaran SD (2001) Bisphosphonates: an overview with special reference to alendronate. Ann Clin Biochem 38:608\u2013623","journal-title":"Ann Clin Biochem"},{"key":"596_CR3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.critrevonc.2006.12.005","volume":"62","author":"R Weitzman","year":"2007","unstructured":"Weitzman R, Sauter N, Eriksen EF, Tarassoff PG, Lacerna LV, Dias R, Altmeyer A, Csermak-Renner K, McGrath L, Lantwicki L, Hohneker JA (2007) Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients\u2014May 2006. Crit Rev Oncol Hematol 62:148\u2013152. doi: 10.1016\/j.critrevonc.2006.12.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"596_CR4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/er.19.1.80","volume":"19","author":"H Fleisch","year":"1998","unstructured":"Fleisch H (1998) Bisphosphonates: mechanisms of action. Endocr Rev 19:80\u2013100","journal-title":"Endocr Rev"},{"key":"596_CR5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bone.2003.07.007","volume":"33","author":"ER Beek van","year":"2003","unstructured":"van Beek ER, Cohen LH, Leroy IM, Ebetino FH, Lowik CW, Papapoulos SE (2003) Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates. Bone 33:805\u2013811","journal-title":"Bone"},{"key":"596_CR6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0278-2391(09)01309-3","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, American Association of Oral and Maxillofacial Surgeons (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update. J Oral Maxillofac Surg 67:2\u201312. doi: 10.1016\/j.joms.2009.01.009","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.joms.2009.03.001","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Carlson ER, Assael LA (2009) Comprehensive review of bisphosphonate therapy: implications for the oral and maxillofacial surgery patient. J Oral Maxillofac Surg 67:1. doi: 10.1016\/j.joms.2009.03.001","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","volume":"65","author":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons","year":"2007","unstructured":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369\u2013376. doi: 10.1016\/j.joms.2006.11.003","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1259\/dmfr\/27458726","volume":"35","author":"S Chiandussi","year":"2006","unstructured":"Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R (2006) Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 35:236\u2013243. doi: 10.1259\/dmfr\/27458726","journal-title":"Dentomaxillofac Radiol"},{"key":"596_CR10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS, Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators","year":"2010","unstructured":"Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS, Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68:243\u2013253. doi: 10.1016\/j.joms.2009.03.050","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR11","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E, American Society for Bone and Mineral Research (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491. doi: 10.1359\/jbmr.0707onj","journal-title":"J Bone Miner Res"},{"key":"596_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcms.2007.06.008","volume":"36","author":"MH Abu-Id","year":"2008","unstructured":"Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PA, Kreusch T (2008) \u201cBis-phossy jaws\u201d\u2014high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Craniomaxillofac Surg 36:95\u2013103. doi: 10.1016\/j.jcms.2007.06.008","journal-title":"J Craniomaxillofac Surg"},{"key":"596_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-160X-6-11","volume":"6","author":"C Walter","year":"2010","unstructured":"Walter C, Al-Nawas B, Frickhofen N, Gamm H, Beck J, Reinsch L, Blum C, Grotz KA, Wagner W (2010) Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients. Head Face Med 6:11. doi: 10.1186\/1746-160X-6-11","journal-title":"Head Face Med"},{"key":"596_CR14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","volume":"23","author":"AO Hoff","year":"2008","unstructured":"Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23:826\u2013836. doi: 10.1359\/jbmr.080205","journal-title":"J Bone Miner Res"},{"key":"596_CR15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415\u2013423. doi: 10.1016\/j.joms.2006.10.061","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"BG Durie","year":"2005","unstructured":"Durie BG, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353:99\u2013102. doi: 10.1056\/NEJM200507073530120 , discussion 99\u2013102","journal-title":"N Engl J Med"},{"key":"596_CR17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","volume":"44","author":"T Boonyapakorn","year":"2008","unstructured":"Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G (2008) Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44:857\u2013869. doi: 10.1016\/j.oraloncology.2007.11.012","journal-title":"Oral Oncol"},{"key":"596_CR18","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1200\/JCO.2008.16.9300","volume":"26","author":"A Badros","year":"2008","unstructured":"Badros A, Terpos E, Katodritou E, Goloubeva O, Kastritis E, Verrou E, Zervas K, Baer MR, Meiller T, Dimopoulos MA (2008) Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Clin Oncol 26:5904\u20135909. doi: 10.1200\/JCO.2008.16.9300","journal-title":"J Clin Oncol"},{"key":"596_CR19","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","volume":"23","author":"A Bamias","year":"2005","unstructured":"Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23:8580\u20138587. doi: 10.1200\/JCO.2005.02.8670","journal-title":"J Clin Oncol"},{"key":"596_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","volume":"102","author":"SL Ruggiero","year":"2006","unstructured":"Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433\u2013441. doi: 10.1016\/j.tripleo.2006.06.004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"596_CR21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"SB Woo","year":"2006","unstructured":"Woo SB, Hellstein JW, Kalmar JR (2006) Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753\u2013761","journal-title":"Ann Intern Med"},{"key":"596_CR22","doi-asserted-by":"crossref","unstructured":"Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, Mucke T, Mast G, Kohnke R, Volkmer E, Haasters F, Lieger O, Iizuka T, Porter S, Campisi G, Colella G, Ploder O, Neff A, Wiltfang J, Ehrenfeld M, Kreusch T, Wolff KD, Sturzenbaum SR, Schieker M, Pautke C (2010) Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence\u2014a multi-centre study. J Craniomaxillofac Surg. doi: 10.1016\/j.jcms.2010.05.009","DOI":"10.1016\/j.jcms.2010.05.009"},{"key":"596_CR23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1592\/phco.28.5.667","volume":"28","author":"AE King","year":"2008","unstructured":"King AE, Umland EM (2008) Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates. Pharmacotherapy 28:667\u2013677. doi: 10.1592\/phco.28.5.667","journal-title":"Pharmacotherapy"},{"key":"596_CR24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","volume":"42","author":"R Rizzoli","year":"2008","unstructured":"Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY (2008) Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42:841\u2013847. doi: 10.1016\/j.bone.2008.01.003","journal-title":"Bone"},{"key":"596_CR25","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.amjmed.2008.12.005","volume":"122","author":"SL Silverman","year":"2009","unstructured":"Silverman SL, Landesberg R (2009) Osteonecrosis of the jaw and the role of bisphosphonates: a critical review. Am J Med 122:S33\u2013S45. doi: 10.1016\/j.amjmed.2008.12.005","journal-title":"Am J Med"},{"key":"596_CR26","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575. doi: 10.1016\/j.joms.2005.07.010","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","volume":"44","author":"IR Reid","year":"2009","unstructured":"Reid IR (2009) Osteonecrosis of the jaw: who gets it, and why? Bone 44:4\u201310. doi: 10.1016\/j.bone.2008.09.012","journal-title":"Bone"},{"key":"596_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joms.2008.10.005","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL (2009) Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development. J Oral Maxillofac Surg 67:13\u201318. doi: 10.1016\/j.joms.2008.10.005","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2141.2008.07504.x","volume":"144","author":"MA Scheper","year":"2009","unstructured":"Scheper MA, Badros A, Chaisuparat R, Cullen KJ, Meiller TF (2009) Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol 144:667\u2013676. doi: 10.1111\/j.1365-2141.2008.07504.x","journal-title":"Br J Haematol"},{"key":"596_CR30","doi-asserted-by":"crossref","unstructured":"Hoefert S, Schmitz I, Tannapfel A, Eufinger H (2009) Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin Oral Investig. doi: 10.1007\/s00784-009-0300-6","DOI":"10.1007\/s00784-009-0300-6"},{"key":"596_CR31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","volume":"66","author":"PP Sedghizadeh","year":"2008","unstructured":"Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW (2008) Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg 66:767\u2013775. doi: 10.1016\/j.joms.2007.11.035","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR32","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.14219\/jada.archive.2009.0049","volume":"140","author":"PP Sedghizadeh","year":"2009","unstructured":"Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW (2009) Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. J Am Dent Assoc 140:1259\u20131265","journal-title":"J Am Dent Assoc"},{"key":"596_CR33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.joms.2008.09.015","volume":"67","author":"S Lehrer","year":"2009","unstructured":"Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, Kogan R (2009) Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene. J Oral Maxillofac Surg 67:159\u2013161. doi: 10.1016\/j.joms.2008.09.015","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR34","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","volume":"136","author":"CA Migliorati","year":"2005","unstructured":"Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 136:1658\u20131668","journal-title":"J Am Dent Assoc"},{"key":"596_CR35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00432-010-0907-7","volume":"136","author":"O Filleul","year":"2010","unstructured":"Filleul O, Crompot E, Saussez S (2010) Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 136:1117\u20131124. doi: 10.1007\/s00432-010-0907-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"596_CR36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.joms.2009.01.003","volume":"67","author":"LA Assael","year":"2009","unstructured":"Assael LA (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 67:35\u201343. doi: 10.1016\/j.joms.2009.01.003","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.breast.2009.07.001","volume":"18","author":"T Fehm","year":"2009","unstructured":"Fehm T, Felsenberg D, Krimmel M, Solomayer E, Wallwiener D, Hadjii P (2009) Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment. Breast 18:213\u2013217. doi: 10.1016\/j.breast.2009.07.001","journal-title":"Breast"},{"key":"596_CR38","first-page":"475.e3","volume":"121","author":"LM Hess","year":"2008","unstructured":"Hess LM, Jeter JM, Benham-Hutchins M, Alberts DS (2008) Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med 121:475.e3\u2013483.e3. doi: 10.1016\/j.amjmed.2008.01.047","journal-title":"Am J Med"},{"key":"596_CR39","doi-asserted-by":"crossref","unstructured":"Aghaloo TL, Felsenfeld AL, Tetradis S (2010) Osteonecrosis of the jaw in a patient on Denosumab. J Oral Maxillofac Surg. doi: 10.1016\/j.joms.2009.10.010","DOI":"10.1016\/j.joms.2009.10.010"},{"key":"596_CR40","doi-asserted-by":"crossref","unstructured":"Van den Wyngaert T, Wouters K, Huizing MT, Vermorken JB (2011) RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem? Support Care Cancer. doi: 10.1007\/s00520-010-1061-0","DOI":"10.1007\/s00520-010-1061-0"},{"key":"596_CR41","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.oraloncology.2009.10.004","volume":"46","author":"N Yarom","year":"2010","unstructured":"Yarom N, Elad S, Madrid C, Migliorati CA (2010) Osteonecrosis of the jaws induced by drugs other than bisphosphonates\u2014a call to update terminology in light of new data. Oral Oncol 46:e1. doi: 10.1016\/j.oraloncology.2009.10.004","journal-title":"Oral Oncol"},{"key":"596_CR42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tripleo.2010.02.020","volume":"110","author":"M Scoletta","year":"2010","unstructured":"Scoletta M, Arduino PG, Dalmasso P, Broccoletti R, Mozzati M (2010) Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:46\u201353. doi: 10.1016\/j.tripleo.2010.02.020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"596_CR43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdn630","volume":"20","author":"T Wyngaert Van den","year":"2009","unstructured":"Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E (2009) Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol 20:331\u2013336. doi: 10.1093\/annonc\/mdn630","journal-title":"Ann Oncol"},{"key":"596_CR44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2009.01.011","volume":"67","author":"JE Fantasia","year":"2009","unstructured":"Fantasia JE (2009) Bisphosphonates\u2014what the dentist needs to know: practical considerations. J Oral Maxillofac Surg 67:53\u201360. doi: 10.1016\/j.joms.2009.01.011","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR45","unstructured":"Ruggiero SL (2010) Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci. doi: 10.1111\/j.1749-6632.2010.05768.x;10.1111\/j.1749-6632.2010.05768.x"},{"key":"596_CR46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/SCS.0b013e3181c347a0","volume":"21","author":"RJ Knight","year":"2010","unstructured":"Knight RJ, Reddy C, Rtshiladze MA, Lvoff G, Sherring D, Marucci D (2010) Bisphosphonate-related osteonecrosis of the jaw: tip of the iceberg. J Craniofac Surg 21:25\u201332. doi: 10.1097\/SCS.0b013e3181c347a0","journal-title":"J Craniofac Surg"},{"key":"596_CR47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1601-5037.2008.00331.x","volume":"7","author":"S Rayman","year":"2009","unstructured":"Rayman S, Almas K, Dincer E (2009) Bisphosphonate-related jaw necrosis: a team approach management and prevention. Int J Dent Hyg 7:90\u201395","journal-title":"Int J Dent Hyg"},{"key":"596_CR48","doi-asserted-by":"crossref","unstructured":"Mucke T, Koschinski J, Deppe H, Wagenpfeil S, Pautke C, Mitchell DA, Wolff KD, Holzle F (2010) Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws. J Cancer Res Clin Oncol. doi: 10.1007\/s00432-010-0953-1","DOI":"10.1007\/s00432-010-0953-1"},{"key":"596_CR49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","volume":"67","author":"ER Carlson","year":"2009","unstructured":"Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67:85\u201395. doi: 10.1016\/j.joms.2009.01.006","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0030-4220(52)90288-0","volume":"5","author":"R Trauner","year":"1952","unstructured":"Trauner R (1952) Alveoloplasty with ridge extensions on the lingual side of the lower jaw to solve the problem of a lower dental prosthesis. Oral Surg Oral Med Oral Pathol 5:340\u2013346","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"596_CR51","first-page":"23","volume":"10","author":"R Trauner","year":"1965","unstructured":"Trauner R (1965) 10 year results of mylohyoid plastic surgery. Fortschr Kiefer Gesichtschir 10:23\u201328","journal-title":"Fortschr Kiefer Gesichtschir"},{"key":"596_CR52","doi-asserted-by":"crossref","first-page":"6258s","DOI":"10.1158\/1078-0432.CCR-06-0840","volume":"12","author":"JJ Body","year":"2006","unstructured":"Body JJ (2006) Breast cancer: bisphosphonate therapy for metastatic bone disease. Clin Cancer Res 12:6258s\u20136263s. doi: 10.1158\/1078-0432.CCR-06-0840","journal-title":"Clin Cancer Res"},{"key":"596_CR53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S8756-3282(03)00112-1","volume":"33","author":"YZ Bagger","year":"2003","unstructured":"Bagger YZ, Tanko LB, Alexandersen P, Ravn P, Christiansen C (2003) Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7\u00a0years after treatment withdrawal. Bone 33:301\u2013307","journal-title":"Bone"},{"key":"596_CR54","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","volume":"65","author":"RP Harper","year":"2007","unstructured":"Harper RP, Fung E (2007) Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1\u201334)]. J Oral Maxillofac Surg 65:573\u2013580. doi: 10.1016\/j.joms.2006.10.076","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"JH Lin","year":"1996","unstructured":"Lin JH (1996) Bisphosphonates: a review of their pharmacokinetic properties. Bone 18:75\u201385","journal-title":"Bone"},{"key":"596_CR56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10103-009-0687-y","volume":"25","author":"P Vescovi","year":"2010","unstructured":"Vescovi P, Manfredi M, Merigo E, Meleti M, Fornaini C, Rocca JP, Nammour S (2010) Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT). Lasers Med Sci 25:101\u2013113. doi: 10.1007\/s10103-009-0687-y","journal-title":"Lasers Med Sci"},{"key":"596_CR57","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","volume":"65","author":"RE Marx","year":"2007","unstructured":"Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65:2397\u20132410. doi: 10.1016\/j.joms.2007.08.003","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR58","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","volume":"20","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, Migkou M, Eleftherakis-Papaiakovou E, Christoulas D, Terpos E, Bamias A (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20:117\u2013120. doi: 10.1093\/annonc\/mdn554","journal-title":"Ann Oncol"},{"key":"596_CR59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"CI Ripamonti","year":"2009","unstructured":"Ripamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, Bareggi C, Ascani L, Cislaghi E (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 20:137\u2013145. doi: 10.1093\/annonc\/mdn526","journal-title":"Ann Oncol"},{"key":"596_CR60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bjoms.2008.05.011","volume":"47","author":"L Gallego","year":"2009","unstructured":"Gallego L, Junquera L (2009) Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws. Br J Oral Maxillofac Surg 47:67\u201368. doi: 10.1016\/j.bjoms.2008.05.011","journal-title":"Br J Oral Maxillofac Surg"},{"key":"596_CR61","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bone.2007.12.225","volume":"42","author":"FP Coxon","year":"2008","unstructured":"Coxon FP, Thompson K, Roelofs AJ, Ebetino FH, Rogers MJ (2008) Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells. Bone 42:848\u2013860. doi: 10.1016\/j.bone.2007.12.225","journal-title":"Bone"},{"key":"596_CR62","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.joms.2004.04.007","volume":"62","author":"RE McMahon","year":"2004","unstructured":"McMahon RE, Bouquot JE, Glueck CJ, Spolnik KJ, Adams WR (2004) Osteonecrosis: a multifactorial etiology. J Oral Maxillofac Surg 62:904\u2013905","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR63","first-page":"455","volume":"103","author":"J Kapitola","year":"2002","unstructured":"Kapitola J, Zak J, Justova V, Lacinova Z (2002) Effect of pamidronate on bone blood flow and serum levels of IGF-I in sham-operated and oophorectomized female rats. Sb Lek 103:455\u2013460","journal-title":"Sb Lek"},{"key":"596_CR64","first-page":"6538","volume":"62","author":"P Fournier","year":"2002","unstructured":"Fournier P, Boissier S, Filleur S, Guglielmi J, Cabon F, Colombel M, Clezardin P (2002) Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62:6538\u20136544","journal-title":"Cancer Res"},{"key":"596_CR65","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/hed.20864","volume":"30","author":"A Wutzl","year":"2008","unstructured":"Wutzl A, Biedermann E, Wanschitz F, Seemann R, Klug C, Baumann A, Watzinger F, Schicho K, Ewers R, Millesi G (2008) Treatment results of bisphosphonate-related osteonecrosis of the jaws. Head Neck 30:1224\u20131230. doi: 10.1002\/hed.20864","journal-title":"Head Neck"},{"key":"596_CR66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00784-009-0311-3","volume":"14","author":"S Elad","year":"2010","unstructured":"Elad S, Gomori MJ, Ben-Ami N, Friedlander-Barenboim S, Regev E, Lazarovici TS, Yarom N (2010) Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation. Clin Oral Investig 14:43\u201350. doi: 10.1007\/s00784-009-0311-3","journal-title":"Clin Oral Investig"},{"key":"596_CR67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/CCO.0b013e32819f820b","volume":"19","author":"T Wyngaert Van den","year":"2007","unstructured":"Van den Wyngaert T, Huizing MT, Vermorken JB (2007) Osteonecrosis of the jaw related to the use of bisphosphonates. Curr Opin Oncol 19:315\u2013322. doi: 10.1097\/CCO.0b013e32819f820b","journal-title":"Curr Opin Oncol"},{"key":"596_CR68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tripleo.2007.01.008","volume":"104","author":"L Montebugnoli","year":"2007","unstructured":"Montebugnoli L, Felicetti L, Gissi DB, Pizzigallo A, Pelliccioni GA, Marchetti C (2007) Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:473\u2013477. doi: 10.1016\/j.tripleo.2007.01.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"596_CR69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","volume":"104","author":"CA Migliorati","year":"2005","unstructured":"Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104:83\u201393. doi: 10.1002\/cncr.21130","journal-title":"Cancer"},{"key":"596_CR70","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2006.09.022","volume":"103","author":"R Diego","year":"2007","unstructured":"Diego R, D'Orto O, Pagani D, Agazzi A, Marzano U, Derada Troletti G, Fontanella W, Pignataro L (2007) Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:e1\u2013e5. doi: 10.1016\/j.tripleo.2006.09.022","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"596_CR71","doi-asserted-by":"crossref","unstructured":"Stockmann P, Vairaktaris E, Wehrhan F, Seiss M, Schwarz S, Spriewald B, Neukam FW, Nkenke E (2009) Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12\u00a0months follow-up. Support Care Cancer. doi: 10.1007\/s00520-009-0688-1","DOI":"10.1007\/s00520-009-0688-1"},{"key":"596_CR72","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.joms.2008.09.037","volume":"67","author":"C Pautke","year":"2009","unstructured":"Pautke C, Bauer F, Tischer T, Kreutzer K, Weitz J, Kesting M, Holzle F, Kolk A, Sturzenbaum SR, Wolff KD (2009) Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 67:471\u2013476. doi: 10.1016\/j.joms.2008.09.037","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR73","doi-asserted-by":"crossref","unstructured":"Wilde F, Heufelder M, Winter K, Hendricks J, Frerich B, Schramm A, Hemprich A (2010) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. doi: 10.1016\/j.tripleo.2010.04.015","DOI":"10.1016\/j.tripleo.2010.04.015"},{"key":"596_CR74","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2008.09.021","volume":"107","author":"K Alons","year":"2009","unstructured":"Alons K, Kuijpers SC, de Jong E, van Merkesteyn JP (2009) Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:e1\u2013e7. doi: 10.1016\/j.tripleo.2008.09.021","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"596_CR75","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.joms.2008.12.057","volume":"67","author":"DC Stanton","year":"2009","unstructured":"Stanton DC, Balasanian E (2009) Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases. J Oral Maxillofac Surg 67:943\u2013950. doi: 10.1016\/j.joms.2008.12.057","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR76","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","volume":"105","author":"A Bedogni","year":"2008","unstructured":"Bedogni A, Blandamura S, Lokmic Z, Palumbo C, Ragazzo M, Ferrari F, Tregnaghi A, Pietrogrande F, Procopio O, Saia G, Ferretti M, Bedogni G, Chiarini L, Ferronato G, Ninfo V, Lo Russo L, Lo Muzio L, Nocini PF (2008) Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:358\u2013364. doi: 10.1016\/j.tripleo.2007.08.040","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"596_CR77","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.joms.2007.03.019","volume":"65","author":"JJ Freiberger","year":"2007","unstructured":"Freiberger JJ, Padilla-Burgos R, Chhoeu AH, Kraft KH, Boneta O, Moon RE, Piantadosi CA (2007) Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg 65:1321\u20131327. doi: 10.1016\/j.joms.2007.03.019","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR78","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/scs.0b013e31857261f","volume":"18","author":"A Agrillo","year":"2007","unstructured":"Agrillo A, Ungari C, Filiaci F, Priore P, Iannetti G (2007) Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis. J Craniofac Surg 18:1071\u20131075. doi: 10.1097\/scs.0b013e31857261f","journal-title":"J Craniofac Surg"},{"key":"596_CR79","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.oraloncology.2010.03.016","volume":"46","author":"C Madrid","year":"2010","unstructured":"Madrid C, Bouferrache K, Abarca M, Jaques B, Broome M (2010) Bisphosphonate-related osteonecrosis of the jaws: how to manage cancer patients. Oral Oncol 46:468\u2013470. doi: 10.1016\/j.oraloncology.2010.03.016","journal-title":"Oral Oncol"},{"key":"596_CR80","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.joms.2010.07.014","volume":"69","author":"C Pautke","year":"2011","unstructured":"Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J, Kreutzer K, Hohlweg-Majert B, Wolff KD, Hafner S, Mast G, Ehrenfeld M, Sturzenbaum SR, Kolk A (2011) Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. J Oral Maxillofac Surg 69:84\u201391. doi: 10.1016\/j.joms.2010.07.014","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR81","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.joms.2006.07.012","volume":"65","author":"SL Engroff","year":"2007","unstructured":"Engroff SL, Kim DD (2007) Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction? J Oral Maxillofac Surg 65:2374\u20132385. doi: 10.1016\/j.joms.2006.07.012","journal-title":"J Oral Maxillofac Surg"},{"key":"596_CR82","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tripleo.2007.11.025","volume":"105","author":"SL Engroff","year":"2008","unstructured":"Engroff SL, Coletti D (2008) Bisphosphonate related osteonecrosis of the palate: report of a case managed with free tissue transfer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:580\u2013582. doi: 10.1016\/j.tripleo.2007.11.025","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"596_CR83","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.joms.2007.06.631","volume":"66","author":"S Ferrari","year":"2008","unstructured":"Ferrari S, Bianchi B, Savi A, Poli T, Multinu A, Balestreri A, Ferri A (2008) Fibula free flap with endosseous implants for reconstructing a resected mandible in bisphosphonate osteonecrosis. J Oral Maxillofac Surg 66:999\u20131003. doi: 10.1016\/j.joms.2007.06.631","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-011-0596-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-011-0596-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-011-0596-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:34:13Z","timestamp":1559111653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-011-0596-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,5]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1007\/s00784-011-0596-x","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,5]]}}}